Trade with Eva: Analytics in action >>

Tuesday, January 30, 2018

-=HCA Healthcare (HCA) reported earnings on Tue 30 January 2018 (BMO)

HCA beats by $0.25, beats on revs; guides FY18 EPS above consensus, revs in-line; imitated quarterly dividend of $0.35/share
  • Reports Q4 (Dec) earnings of $2.12 per share, excluding non-recurring items, $0.25 better thanthe Capital IQ Consensus of $1.87; revenues rose 8.7% year/year to $11.56 bln vs the $11.19 bln Capital IQ Consensus. The Company recognized a tax benefit of $2 million, or $0.01 per diluted share, in the fourth quarter of 2017 compared to a $33 million tax benefit, or $0.09 per diluted share, in the fourth quarter of 2016 for excess tax benefits related to employee equity award settlements recorded as a component of the provision for income taxes.
  • Results for the fourth quarter of 2017 include a non-cash increase in the Company's provision for income taxes of $301 million, or $0.83 per diluted share, related to the estimated impact of the Tax Cuts and Jobs Act on our deferred tax assets and liabilities.
  • Adjusted EBITDA for the fourth quarter of 2017 increased 7.1 percent to $2.362 billion from $2.206 billion in the prior year period. Adjusted EBITDA is a non-GAAP financial measure.
  • HCA today announced that its Board of Directors declared a quarterly cash dividend of $0.35 per share on the Company's common stock. The dividend will be paid on March 30, 2018 to stockholders of record at the close of business on March 1, 2018.
  • Co issues guidance for FY18, sees EPS of $8.50-9.00, excluding non-recurring items, vs. $7.56 Capital IQ Consensus Estimate; sees FY18 revs of $45.0-46.0 bln vs. $45.32 bln Capital IQ Consensus Estimate. 

No comments:

Post a Comment